We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+14.93%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.49B
AUM Growth
-$310M
Cap. Flow
-$220M
Cap. Flow %
-4%
Top 10 Hldgs %
20.85%
Holding
223
New
43
Increased
76
Reduced
62
Closed
19

Top Buys

Rank Stock Value
1
GEV icon
GE Vernova
GEV
+$78M
2
DTM icon
DT Midstream
DTM
+$57.2M
3
WDAY icon
Workday
WDAY
+$50.1M
4
LNG icon
Cheniere Energy
LNG
+$48M
5
BPMC
Blueprint Medicines
BPMC
+$47M

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$95.2M
2
WCN
Waste Connections
WCN
+$90.6M
3
TT icon
Trane Technologies
TT
+$86.8M
4
DHI icon
D.R. Horton
DHI
+$68.1M
5
ROL icon
Rollins
ROL
+$57.3M

Sector Composition

Rank Sector Weight
1 Healthcare 37.19%
2 Technology 20.42%
3 Industrials 16.23%
4 Consumer Discretionary 7.92%
5 Energy 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGEN icon
101
Repligen
RGEN
$7.03B
$17.1M 0.31%
119,000
– –
IEX icon
102
IDEX
IEX
$17.3B
$16.8M 0.31%
80,168
+8,581
+12% +$1.88M
NOVT icon
103
Novanta
NOVT
$4.95B
$16.7M 0.3%
109,191
-17,239
-14% -$2.92M
CELC icon
104
Celcuity
CELC
$4.27B
$16.6M 0.3%
1,265,653
-269,347
-18% -$3.8M
RVMD icon
105
Revolution Medicines
RVMD
$40.9B
$16.3M 0.3%
372,229
-150,822
-29% -$7.61M
PRVA icon
106
Privia Health
PRVA
$3.01B
$16.1M 0.29%
822,438
– –
CRWD icon
107
CrowdStrike
CRWD
$189B
$15.9M 0.29%
186,080
-576,108
-76% -$47.9M
KLAC icon
108
KLA
KLAC
$236B
$15.9M 0.29%
252,110
-323,060
-56% -$21.8M
ACAD icon
109
Acadia Pharmaceuticals
ACAD
$4.55B
$15.6M 0.29%
852,845
+275,345
+48% +$4.44M
SNDX icon
110
Syndax Pharmaceuticals
SNDX
$1.73B
$15.6M 0.28%
1,178,062
+391,072
+50% +$6.69M
FICO icon
111
Fair Isaac
FICO
$26.4B
$15.5M 0.28%
7,768
+6,557
+541% +$14M
KRYS icon
112
Krystal Biotech
KRYS
$10.8B
$15M 0.27%
95,781
– –
TYL icon
113
Tyler Technologies
TYL
$13.3B
$14.7M 0.27%
+25,508
New +$15.4M
PNFP icon
114
Pinnacle Financial Partners Inc
PNFP
$15.8B
$14.7M 0.27%
128,411
+65,885
+105% +$7.43M
BBIO icon
115
BridgeBio Pharma
BBIO
$16.1B
$14.6M 0.27%
532,192
-184,735
-26% -$4.77M
KNTK icon
116
Kinetik
KNTK
$3.68B
$14.3M 0.26%
+252,971
New +$13.7M
HUBB icon
117
Hubbell
HUBB
$25B
$14M 0.25%
33,362
+30,728
+1,167% +$13.7M
ZNTL icon
118
Zentalis Pharmaceuticals
ZNTL
$350M
$13.6M 0.25%
4,475,054
-4,072,842
-48% -$13.3M
RLI icon
119
RLI Corp
RLI
$5.62B
$13.4M 0.24%
163,154
+16,226
+11% +$1.35M
AVB icon
120
AvalonBay Communities
AVB
$26.8B
$13.3M 0.24%
60,544
-91,864
-60% -$20.7M
CDW icon
121
CDW
CDW
$18.6B
$13.1M 0.24%
75,151
-144,870
-66% -$28.1M
FHN icon
122
First Horizon
FHN
$12.1B
$13.1M 0.24%
+648,224
New +$12.2M
POOL icon
123
Pool Corp
POOL
$6.95B
$13M 0.24%
38,118
-126,733
-77% -$46.2M
NTAP icon
124
NetApp
NTAP
$34.1B
$12.7M 0.23%
109,616
+14,194
+15% +$1.73M
GPI icon
125
Group 1 Automotive
GPI
$3.53B
$12.4M 0.23%
29,524
-5,419
-16% -$2.14M
3 4
5
6 7

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Eventide Asset Management held 223 positions worth $5.49B, down 5.3% from $5.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Eventide Asset Management withdrew a net $220M in Q4 2024, closing 19 positions and reducing 62 holdings. Its most notable exit was Idexx Laboratories, an estimated $95.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

Against the trend, Eventide Asset Management opened a new position in GE Vernova worth $82.1M.

  • Eventide Asset Management's largest Q4 2024 buy was GE Vernova: 249,514 shares worth $82.1M.
  • Eventide Asset Management added most to Workday in Q4 2024, an estimated $50.1M increase.
  • Eventide Asset Management's biggest Q4 2024 reduction was Waste Connections, cutting an estimated $90.6M.
  • Eventide Asset Management fully exited Idexx Laboratories in Q4 2024, selling an estimated $95.2M.
  • Eventide Asset Management's ten largest holdings make up 21% of its $5.49B portfolio in Q4 2024.
  • Eventide Asset Management opened 43 new positions and closed 19 in Q4 2024.
  • Eventide Asset Management's portfolio value fell 5.3% quarter-over-quarter to $5.49B.

Based on Eventide Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.